ArticleFrontiers in oncology2022

Monocarboxylate transporter upregulation in induced regulatory T cells promotes resistance to anti-PD-1 therapy in hepatocellular carcinoma patients.

Jinren Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.